Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mind Medicine (MindMed) Inc.

8.58
+0.51006.32%
Post-market: 8.610.0300+0.35%19:59 EDT
Volume:1.29M
Turnover:10.86M
Market Cap:648.25M
PE:-8.10
High:8.60
Open:8.18
Low:8.15
Close:8.07
Loading ...

MindMed Announces Inducement Grants for New Employees with Four-Year Vesting Plan

Reuters
·
15 Jul

Evercore ISI Sticks to Its Buy Rating for Mind Medicine (MNMD)

TIPRANKS
·
12 Jul

CEO Robert Barrow Reports Disposal of Common Shares in Mind Medicine (MindMed) Inc

Reuters
·
27 Jun

Incannex Healthcare and Mind Medicine Australia Launch Joint Venture for Psychedelic-Assisted Therapy Clinic in Melbourne

Reuters
·
17 Jun

Mind Medicine (MindMed) Inc. Conducted Annual Shareholder Meeting

Reuters
·
17 Jun

MindMed Announces Inducement Grants for New Employees with Options to Purchase 128,750 Shares

Reuters
·
10 Jun

Mind Medicine (MindMed) Inc. Files Initial Beneficial Ownership Statement for CFO Brandi Roberts

Reuters
·
03 Jun

Mind Medicine (MNMD) Initiated with a Buy at Oppenheimer

TIPRANKS
·
02 Jun

Mind Medicine (MNMD) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
29 May

MindMed Inc. to Present at Jefferies Global Healthcare Conference

Reuters
·
28 May

Mind Medicine Names Brandi Roberts CFO

MT Newswires Live
·
27 May

MindMed Appoints Brandi Roberts as Chief Financial Officer to Strengthen Executive Team

Reuters
·
27 May

MindMed Strengthens Executive Team With Appointment of Brandi Roberts, Cpa, as Chief Financial Officer

THOMSON REUTERS
·
27 May

MindMed Announces Inducement Grants for New Employees with Four-Year Vesting Plan

Reuters
·
20 May

MindMed to Present at RBC Capital Markets Global Healthcare Conference in New York

Reuters
·
13 May

Mind Medicine Is Maintained at Buy by Chardan Capital

Dow Jones
·
09 May

Mind Medicine (MindMed) Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Mind Medicine Q1 EPS $(0.35) Beats $(0.38) Estimate

Benzinga
·
08 May

BRIEF-MindMed Q1 Net Income USD -23.348 Million

Reuters
·
08 May

H.C. Wainwright Sticks to Their Buy Rating for Mind Medicine (MNMD)

TIPRANKS
·
01 May